Global Stem Cell Therapy for Multiple Sclerosis Market Research Report 2023

Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision, and tingling.

The global Stem Cell Therapy for Multiple Sclerosis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The introduction of mesenchymal stem cells therapy is one of the most promising investigational approach to treat multiple sclerosis, the global multiple sclerosis market will witness growth in the forthcoming years. it has been observed that the American cryostem and celgene cellular therapeutics have their stem cell therapy candidates for the treatment of multiple sclerosis in phase I stage of development.

This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Multiple Sclerosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Multiple Sclerosis.

The Stem Cell Therapy for Multiple Sclerosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Stem Cell Therapy for Multiple Sclerosis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stem Cell Therapy for Multiple Sclerosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Intravenous

1.2.3 Intracerebroventricular

1.3 Market by Application

1.3.1 Global Stem Cell Therapy for Multiple Sclerosis Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Relapsing-Remitting Multiple Sclerosis (RRMS)

1.3.3 Primary Progressive Multiple Sclerosis (PPMS)

1.3.4 Secondary Progressive Multiple Sclerosis (SPMS)

1.3.5 Progressive Relapsing Multiple Sclerosis (PRMS)

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Perspective (2018-2029)

2.2 Stem Cell Therapy for Multiple Sclerosis Growth Trends by Region

2.2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Region (2018-2023)

2.2.3 Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Region (2024-2029)

2.3 Stem Cell Therapy for Multiple Sclerosis Market Dynamics

2.3.1 Stem Cell Therapy for Multiple Sclerosis Industry Trends

2.3.2 Stem Cell Therapy for Multiple Sclerosis Market Drivers

2.3.3 Stem Cell Therapy for Multiple Sclerosis Market Challenges

2.3.4 Stem Cell Therapy for Multiple Sclerosis Market Restraints

3.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue

3.1.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue (2018-2023)

3.1.2 Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Players (2018-2023)

3.2 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Stem Cell Therapy for Multiple Sclerosis Revenue

3.4 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio

3.4.1 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Multiple Sclerosis Revenue in 2022

3.5 Stem Cell Therapy for Multiple Sclerosis Key Players Head office and Area Served

3.6 Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service

3.7 Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Type (2018-2023)

4.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2024-2029)

5.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Application (2018-2023)

5.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2024-2029)

6.1 North America Stem Cell Therapy for Multiple Sclerosis Market Size (2018-2029)

6.2 North America Stem Cell Therapy for Multiple Sclerosis Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2018-2023)

6.4 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size (2018-2029)

7.2 Europe Stem Cell Therapy for Multiple Sclerosis Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2018-2023)

7.4 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size (2018-2029)

8.2 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2018-2023)

8.4 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size (2018-2029)

9.2 Latin America Stem Cell Therapy for Multiple Sclerosis Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2018-2023)

9.4 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size (2018-2029)

10.2 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2018-2023)

10.4 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 American CryoStem

11.1.1 American CryoStem Company Detail

11.1.2 American CryoStem Business Overview

11.1.3 American CryoStem Stem Cell Therapy for Multiple Sclerosis Introduction

11.1.4 American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023)

11.1.5 American CryoStem Recent Development

11.2 Athersys

11.2.1 Athersys Company Detail

11.2.2 Athersys Business Overview

11.2.3 Athersys Stem Cell Therapy for Multiple Sclerosis Introduction

11.2.4 Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023)

11.2.5 Athersys Recent Development

11.3 Celgene Cellular Therapeutics

11.3.1 Celgene Cellular Therapeutics Company Detail

11.3.2 Celgene Cellular Therapeutics Business Overview

11.3.3 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Introduction

11.3.4 Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023)

11.3.5 Celgene Cellular Therapeutics Recent Development

11.4 Cell Cure Neurosciences

11.4.1 Cell Cure Neurosciences Company Detail

11.4.2 Cell Cure Neurosciences Business Overview

11.4.3 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Introduction

11.4.4 Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023)

11.4.5 Cell Cure Neurosciences Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Intravenous

    Table 3. Key Players of Intracerebroventricular

    Table 4. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2018-2023)

    Table 8. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2024-2029)

    Table 10. Stem Cell Therapy for Multiple Sclerosis Market Trends

    Table 11. Stem Cell Therapy for Multiple Sclerosis Market Drivers

    Table 12. Stem Cell Therapy for Multiple Sclerosis Market Challenges

    Table 13. Stem Cell Therapy for Multiple Sclerosis Market Restraints

    Table 14. Global Stem Cell Therapy for Multiple Sclerosis Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players (2018-2023)

    Table 16. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2022)

    Table 17. Ranking of Global Top Stem Cell Therapy for Multiple Sclerosis Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service

    Table 21. Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2018-2023)

    Table 25. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2024-2029)

    Table 27. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Application (2018-2023)

    Table 29. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Application (2024-2029)

    Table 31. North America Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2024-2029) & (US$ Million)

    Table 46. American CryoStem Company Detail

    Table 47. American CryoStem Business Overview

    Table 48. American CryoStem Stem Cell Therapy for Multiple Sclerosis Product

    Table 49. American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023) & (US$ Million)

    Table 50. American CryoStem Recent Development

    Table 51. Athersys Company Detail

    Table 52. Athersys Business Overview

    Table 53. Athersys Stem Cell Therapy for Multiple Sclerosis Product

    Table 54. Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023) & (US$ Million)

    Table 55. Athersys Recent Development

    Table 56. Celgene Cellular Therapeutics Company Detail

    Table 57. Celgene Cellular Therapeutics Business Overview

    Table 58. Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Product

    Table 59. Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023) & (US$ Million)

    Table 60. Celgene Cellular Therapeutics Recent Development

    Table 61. Cell Cure Neurosciences Company Detail

    Table 62. Cell Cure Neurosciences Business Overview

    Table 63. Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Product

    Table 64. Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023) & (US$ Million)

    Table 65. Cell Cure Neurosciences Recent Development

    Table 66. Research Programs/Design for This Report

    Table 67. Key Data Information from Secondary Sources

    Table 68. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Stem Cell Therapy for Multiple Sclerosis Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Type: 2022 VS 2029

    Figure 3. Intravenous Features

    Figure 4. Intracerebroventricular Features

    Figure 5. Global Stem Cell Therapy for Multiple Sclerosis Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application: 2022 VS 2029

    Figure 7. Relapsing-Remitting Multiple Sclerosis (RRMS) Case Studies

    Figure 8. Primary Progressive Multiple Sclerosis (PPMS) Case Studies

    Figure 9. Secondary Progressive Multiple Sclerosis (SPMS) Case Studies

    Figure 10. Progressive Relapsing Multiple Sclerosis (PRMS) Case Studies

    Figure 11. Stem Cell Therapy for Multiple Sclerosis Report Years Considered

    Figure 12. Global Stem Cell Therapy for Multiple Sclerosis Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Stem Cell Therapy for Multiple Sclerosis Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Region: 2022 VS 2029

    Figure 15. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players in 2022

    Figure 16. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue in 2022

    Figure 18. North America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2018-2029)

    Figure 20. United States Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2018-2029)

    Figure 24. Germany Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2018-2029)

    Figure 32. China Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2018-2029)

    Figure 40. Mexico Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2018-2029)

    Figure 44. Turkey Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. American CryoStem Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023)

    Figure 47. Athersys Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023)

    Figure 48. Celgene Cellular Therapeutics Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023)

    Figure 49. Cell Cure Neurosciences Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2018-2023)

    Figure 50. Bottom-up and Top-down Approaches for This Report

    Figure 51. Data Triangulation

    Figure 52. Key Executives Interviewed